RenaudBonnet

Practice Leader Private Equity

Paris + 33.1.56.59.39.14

Renaud Bonnet intervient dans les domaines du private equity, des fusions-acquisitions et du droit boursier. Il co-dirige la pratique Private Equity de Jones Day dans le monde.

Il accompagne principalement des entreprises de croissance (cotées ou non) et leurs actionnaires dirigeants, industriels ou financiers, notamment dans les secteurs du logiciel, de l'internet et des biotech/medtech, tout au long de leur développement depuis leur création jusqu'à leur adossement industriel ou leur introduction en bourse et, au-delà, dans leur vie de sociétés cotées. A ce titre, il conduit chaque année un grand nombre d'opérations de capital-risque, LBO, fusions-acquisitions et boursières (IPOs, placements privés, OPAs,...).

Les entreprises récemment représentées par Renaud Bonnet comptent notamment Adocia, Advicenne, Ansys, Cellectis, Criteo, Devialet, EcoVadis, HRA Pharma, Ivalua, Mauna Kea Technologies, ManoMano, Nanobiotix, Planisware, Prodways, Sigfox, Talend, TxCell, Voltalia et Voluntis, et les investisseurs stratégiques ou financiers, Abingworth, Alven, Bain Capital Ventures, Bpifrance, Creadev, Danone Ventures, Elaia, Felix Capital, Goldman Sachs, Hi Inov, Idinvest, Illumina Ventures, Khazana, Medicxi Ventures, Orange, Seventure, Temasek et Sofinnova.

Parmi les transactions représentatives de son expérience figurent : plus de 40 introductions en bourse en France et celles de Criteo, Cellectis et Talend sur le Nasdaq ; les OPAs de Completel, Wavecom, Assystem et TxCell ; les LBO d’HRA Pharma par Astorg et Goldman Sachs, d’Orolia par Eurazeo, d'A2Mac1 par Five Arrows et de Brico Privé pat Florac ; les cessions de Novexel à AstraZeneca et de Synthesio à IPSOS ; l'acquisition de sociétés de technologie françaises par Autodesk, Criteo, SAP et Ansys ; et les derniers tours de financement de Devialet, ManoMano, Ivalua ou encore EcoVadis.

Renaud Bonnet a été membre de la commission consultative “Opérations et information financières des émetteurs” de l'AMF de 2017 à 2019.

Expérience

  • Creadev and France 2i participate in €60 million Series C financing round of M2i LifesciencesJones Day represented Creadev SAS and France 2i (Raise Impact) in connection with the €60 million (US$66 million) Series C round of financing of M2i Lifesciences, a world leader in the field of pheromones for crop protection, animal health and human health, producing agricultural chemical products.
  • Bpifrance, Alven, and Piton to sell Meilleurs Agents to The AVIV Group for €200 million (US$220.7 million)Jones Day is representing Bpifrance, Alven, and Piton as selling shareholders in the €200 million (US$220.7 million) sale of Meilleurs Agents, a French-based developer and operator of an online platform dedicated to the French real estate market, to The AVIV Group, a subsidiary of Axel Springer SE.
  • Voltalia completes €376 million capital increase with shareholders’ preferential subscription rightsJones Day represented Voltalia S.A. in connection with its €376 million offering by way of preferential subscription rights allocated to Voltalia's existing shareholders in a public offering in France and internationally in private placements to institutional investors.
  • SuperSonic Imagine acquired by Hologic, Inc.Jones Day advised Supersonic Imagine and its main shareholders in connection with the acquisition of a controlling stake followed by a tender offer by Hologic, Inc. based on an enterprise value of circa US$85 million.
  • Bpifrance participates in €70 million Series C financing round of PayFitJones Day represented Bpifrance in connection with the €70 million (US$78.5 million) Series C round of financing of PayFit, a French company developing and marketing a payroll and HR management software, led by Eurazeo and Bpifrance.
  • Ivalua raises $60 million in financing roundJones Day represented Ivalua SAS, a leading provider of global spend management cloud solutions, in connection with its $60 million round of financing led by Tiger Global Management.
  • Bain Capital Ventures participates in $70 million Series C financing round of MiraklJones Day represented Bain Capital Ventures in connection with the $70 million Series C round of financing of Mirakl, a global leader in e-commerce marketplace platforms.
  • Educapital, Hi Inov, ISAI Gestion, and Siparex Proximité Innovation invest €36 million in 360LearningJones Day represented Educapital, Hi Inov, ISAI Gestion, and Siparex Proximité Innovation in connection with their €36 million (US$41 million) investment in 360Learning, a French company that develops an automated machine learning platform that enables is clients to build predictive models.
  • Sofinnova, Valquest, and Supernova participate in €21 million financing round of AfyrenJones Day represented Sofinnova Partners, Valquest Partners, and Supernova in connection with the €21 million (US$23.7 million) round of financing of Afyren, a start-up in bioprocess and microbiology engineering for valorization of non-food biomass.
  • Bpifrance and Danone Manifesto Ventures participate in €25 million Series B financing round of AgricoolJones Day represented Bpifrance and Danone Manifesto Ventures, as lead investors, in connection with the €25 million (US$28.2 million) Series B financing round of Agricool, a greentech company developing and using containers to grow fruits and vegetables in urban areas.
  • ManoMano completes €110 million Series D roundJones Day represented ManoMano, an online marketplace specializing in the sale of DIY, home improvement, and gardening products, in connection with its €110 million (US$123.5 million) Series D round led by Eurazeo Growth, Aglae Ventures, and BPI Large Venture alongside General Atlantic, Partech, and Piton.
  • Voluntis completes €30.1 million IPO on regulated market of Euronext in ParisJones Day advised Voluntis S.A., a French company specializing in therapeutic software, and Bryan, Garnier & Co and Oddo BHF SCA, joint lead managers and joint bookrunners, in connection with Voluntis' €30.1 million (US$34.9 million) initial public offering on the regulated market of Euronext in Paris.
  • Brico Privé sold to Florac InvestissementsJones Day advised Brico Privé SAS, the leading French online flash sales platform dedicated to do-it-yourself (DIY), gardening and home-improvement, its management, and Ardian in connection with the leveraged buy-out of Brico Privé by Florac Investissements.
  • ANSYS acquires OPTISJones Day advised ANSYS, Inc., the global leader and innovator of engineering simulation software, on its acquisition of OPTIS, a premier provider of software for scientific simulation of light, human vision, and physics-based visualization.
  • Talend completes $188.4 million secondary offering of American Depositary Shares on NASDAQ by Selling ShareholdersJones Day represented Talend SA, a French global leader in cloud and big data integration software, in connection with the $188.4 million secondary public offering of American Depositary (each representing one of its ordinary shares) on NASDAQ, by investment funds affiliated with Silver Lake Sumeru and investment funds affiliated with Balderton Capital.
  • Recommerce raises €50 million from Capzanine and CreadevJones Day represented Recommerce, a provider of smartphone buyback and resale solutions, and its historical investors, including Seventure Partners and Fonds Ambition Numérique, in connection with a €50 million investment in Recommerce by Capzanine and Creadev.
  • A2Mac1 sold to Five Arrows Principal InvestmentsJones Day advised A2Mac1, a leading player in benchmarking data for the automotive industry, and the selling founders in connection with the leveraged buy-out by Five Arrows Principal Investments.
  • Cellectis completes $164 million follow-on public offering of American Depositary Shares on NASDAQJones Day represented Cellectis S.A., a French clinical-stage biopharmaceutical developer of innovative cancer treatments using gene editing technologies, in connection with a $164 million public offering of American Depositary Shares on NASDAQ, underwritten by Goldman Sachs & Co. LLC, Citigroup, and Barclays.
  • Reverse sale of Genticel to GenKyoTex SA to become GenkyotexJones Day advised Genticel SA in connection with its reverse sale to the shareholders of GenKyoTex who received approximately 80 percent of the share capital of Genticel in remuneration of their contribution of GenKyoTex shares to Genticel.
  • Interventions

    • 29 janvier 2014
      Le private equity en 2014 : tendances et opportunités
    • 29 janvier 2013
      Le Private Equity : où en sommes-nous ?
    • 20 septembre 2012
      Le financement des PME: actualités juridiques et tendances de marché - en partenariat avec NYSE Euronext et Société Générale
    • September 20, 2012
      SME Financing: legal news and market trends – in collaboration with NYSE Euronext and Société Générale
    • 5 avril 2011
      Atelier « Fusions & Acquisitions » de France Biotech - Le point de vue de l'avocat, intervention de Renaud Bonnet
    • 17 juin 2009
      Introductions en bourse : la mission de l’avocat conseil et la problématique règlementaire, Conférence “Penser à votre introduction en bourse : osé ... mais peut-être astucieux ! ” organisée par la Société Générale
    • 3 avril 2007
      Introductions en bourse : feuille de route pratique
    • 18 mai 2006
      Petit déjeuner thématique "Stock options, BCE, actions gratuites"
    • 14 mars 2006
      Cours à l'ESSEC, "Mécanisme d'incitation des managers"
    *We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.